The Myeloid Mineralocorticoid Receptor Regulates Dermal Angiogenesis and Inflammation in Glucocorticoid-Induced Impaired Wound Healing

    Van Tuan Nguyen, Qui Trung Ngô, Roberto Palacios, Toshifumi Nakamura, Nicolette Farman, S. Aractingi, Frédéric Jaisser
    TLDR Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.
    The study explored the role of the mineralocorticoid receptor (MR) in glucocorticoid-induced impaired wound healing, particularly its effects on angiogenesis and inflammation. It was found that MR activation in myeloid cells contributed to delayed wound healing by prolonging inflammation and impairing angiogenesis. The use of MR antagonists, such as canrenoate, improved healing by enhancing dermal angiogenesis and promoting a switch in macrophages from a pro-inflammatory to an anti-inflammatory phenotype. The research suggested that targeting MR in myeloid cells could be a therapeutic strategy to improve wound healing in glucocorticoid-treated skin, highlighting the potential of topical MR inhibitors for patients with delayed healing due to glucocorticoid treatments.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 6 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  43 upvotes 6 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community When someone posts a scalp tension theory

      in Satire  263 upvotes 4 years ago
      Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.

      community Group Buy for MR antagonist finerenone

      in Product  11 upvotes 2 years ago
      User discusses group buy for finerenone, a third-gen mineralocorticoid antagonist for hair loss treatment. Finerenone inhibits TGFb, NOX, and ROS, and improves renal and cardiac function; topical dose should be no more than 10mg per day.

      community Dutasteride is amazing even for women with FAGA!

      in Female  151 upvotes 5 months ago
      Dutasteride significantly improved hair health and reduced shedding for a woman with PCOS and hyperandrogenism, without causing depression or anxiety, unlike finasteride. Dutasteride also helped with PMDD symptoms and had no side effects, though it changed hair texture.

      community risks with finasteride and dutasteride

      in Research/Science  139 upvotes 6 months ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

    Similar Research

    5 / 459 results